Mallinckrodt’s Niemann-Pick Type C drug fails to hit trial target

2018-11-08 12:16:03
UK-based Mallinckrodt has revealed that its experimental therapy for Niemann-Pick Type C failed to hit targets in a recently completed registration trial.The firm did not reveal any specific data, but said that VTS-270 did not show a statistically si...

FDA Approves Dsuvia FDA Approves Dsuvia (sufentanil) Sublingual Tablets for Severe Pain

2018-11-04 10:23:40
REDWOOD CITY, Calif., Nov. 2, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in a medically supervised set...

PM Modi Announces Pharma clusters for MSMEs

2018-11-02 15:31:47
PM Modi said that government will set up pharma clusters for MSMEs. Centre to bear 70% of setup cost. He also said that the Govt is to offer Rs 6,000 crore technology upgradation package for MSMEs. hhhRead more at://

Singh brothers & Daiichi case: High Court orders debtors not to sell assets

2018-11-01 08:37:58
New Delhi: The high court has told seven companies owing money to Malvinder and Shivinder Singh not to part with any assets like property so that there are sufficient funds to pay Daiichi Sankyo's arbitration award against the brothers. If these comp...

FDA Approves Hyrimoz FDA Approves Hyrimoz (adalimumab-adaz), a Biosimilar to Humira

2018-11-01 08:02:42
Holzkirchen, Germany, October 31, 2018 - Sandoz, a Novartis division and the pioneer and global leader in biosimilars, today announced that the US Food and Drug Administration (FDA) approved its biosimilar, Hyrimoz (adalimumab-adaz). The FDA granted...

FDA Approves Bijuva (estradiol and progesterone) Capsules for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause

2018-10-30 11:02:20
BOCA RATON, Fla.--(BUSINESS WIRE)--Oct. 29, 2018-- TherapeuticsMD, Inc, an innovative women’s healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved Bijuva (estradiol and progesterone) capsules, 1 m...

Novartis announces clinical collaboration with Pfizer to advance the treatment of NASH ...29 October 2018

2018-10-30 10:37:15
Novartis announced today that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the treatment of NASH, including an Acetyl CoA-Carboxylase (ACC) Inhib...

Good Distribution Practices for pharmaceutical products coming soon

2018-10-29 15:57:27

Antiepileptic drugs linked to higher risk of stroke in persons with Alzheimer’s disease, By By EP News Bureau on October 10, 2018

2018-10-10 18:59:40
The risk did not differ between old and new antiepileptic drugs; the results were published in the Journal of the American Heart AssociationAntiepileptic drug use is associated with an increased risk of stroke among persons with Alzheimer’s disease,...

FDA Approves Revcovi (elapegademase-lvlr) for Adenosine Deaminase Severe Combined Immune Deficiency (ADA-SCID)

2018-10-09 15:16:07
GAITHERSBURG, Md.--(BUSINESS WIRE) October 05, 2018 --Leadiant Biosciences, Inc. today announced that the Food and Drug Administration (FDA) has granted approval to Revcovi™ (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replaceme...